Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intra-arterial thrombolysis.

J L Saver1

  • 1Stroke Center and Department of Neurology, University of California, Los Angeles, USA.

Neurology
|September 12, 2001
PubMed
Summary
This summary is machine-generated.

Intra-arterial thrombolysis directly targets clots in acute ischemic stroke, showing higher recanalization and better outcomes than intravenous methods. This emerging therapy offers a promising approach for stroke treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated Assessment of the DWI-FLAIR Mismatch in Patients with Acute Ischemic Stroke: Added Value to Routine Clinical Practice.

AJNR. American journal of neuroradiology·2024
Same author

Overestimation of ischemic core on baseline MRI in acute stroke.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2024
Same author

CTP-based estimated ischemic core: A comparative multicenter study between Olea and RAPID software.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2023
Same author

Reduced Leukoaraiosis, Noncardiac Embolic Stroke Etiology, and Shorter Thrombus Length Indicate Good Leptomeningeal Collateral Flow in Embolic Large-Vessel Occlusion.

AJNR. American journal of neuroradiology·2021
Same author

Effect of atrial fibrillation on endovascular thrombectomy for acute ischemic stroke. A meta-analysis of individual patient data from six randomised trials: Results from the HERMES collaboration.

European stroke journal·2020
Same author

Perfusion Parameter Thresholds That Discriminate Ischemic Core Vary with Time from Onset in Acute Ischemic Stroke.

AJNR. American journal of neuroradiology·2020
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Vascular Medicine
  • Interventional Radiology

Background:

  • Acute ischemic stroke remains a leading cause of disability.
  • Intravenous thrombolysis has limitations in achieving timely and complete reperfusion.
  • Emerging endovascular techniques offer targeted treatment strategies.

Purpose of the Study:

  • To evaluate the efficacy and safety of intra-arterial (IA) thrombolysis for acute ischemic stroke.
  • To compare IA thrombolysis with intravenous thrombolysis in terms of recanalization rates and clinical outcomes.
  • To explore the role of advanced imaging in assessing IA thrombolysis effects.

Main Methods:

  • IA thrombolysis involves navigating a microcatheter to deliver fibrinolytic agents directly to the thrombus.

Related Experiment Videos

  • The Prolyse in Acute Cerebral Thromboembolism II (PROACT II) trial was the first randomized Phase III trial for IA thrombolysis.
  • Magnetic Resonance Imaging (MRI) studies were used to assess tissue salvage and perfusion-deficiency mismatch.

    • Main Results:

    • IA thrombolysis achieved higher recanalization rates compared to intravenous thrombolysis.
    • The PROACT II trial demonstrated improved clinical outcomes with IA therapy initiated up to 6 hours post-symptom onset.
    • MRI confirmed tissue rescue and salvage in patients treated with IA thrombolysis, even with early diffusion abnormalities.

    Conclusions:

    • IA thrombolysis is a promising and effective treatment strategy for acute ischemic stroke.
    • IA therapy offers targeted delivery of lytic agents, minimizing systemic exposure and maximizing clot penetration.
    • Combined IA and intravenous thrombolysis, along with mechanical reperfusion techniques, are likely to be refined and widely adopted therapies.